OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Crohn's and obesity together
Disease control Recruiting nowThis study tests whether adding tirzepatide (a weight-loss drug) to mirikizumab (an anti-inflammatory drug) helps adults with both active Crohn's disease and obesity or overweight. About 290 participants will receive either mirikizumab alone or mirikizumab plus tirzepatide for up…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 01:52 UTC
-
New combo aims to tame gut inflammation and shed pounds together
Disease control Recruiting nowThis study tests whether adding tirzepatide (a weight-loss drug) to mirikizumab (an anti-inflammatory drug) helps people with moderate-to-severe ulcerative colitis who are also overweight or obese. About 350 adults will receive either both drugs or mirikizumab alone for up to 52 …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New weekly shot shows promise for major weight loss in obesity trial
Disease control Recruiting nowThis study tests a once-weekly injection called enicepatide for weight loss in 2000 adults with obesity or overweight who do not have diabetes. Participants must have a BMI of 30 or higher, or a BMI of 27 with a weight-related health issue like high blood pressure. The main goal …
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 01:48 UTC
-
New weekly shot could help people with obesity and diabetes shed pounds
Disease control Recruiting nowThis study tests a new weekly injection called enicepatide to help people with obesity or overweight and type 2 diabetes lose weight. About 1,600 participants will receive either the drug or a placebo for 72 weeks. The main goal is to see how much weight they lose and if the drug…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
New obesity drug tested for safety with heart and cholesterol meds
Knowledge-focused Recruiting nowThis early-stage study looks at how a new injectable drug (GZR18) affects stomach emptying and interacts with common medications like digoxin, rosuvastatin, and warfarin in 60 overweight or obese adults. Participants will receive the drug and then take these other medicines to se…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC